Buparlisib plus carboplatin or lomustine in patients with recurrent glioblastoma: a phase Ib/II, open-label, multicentre, randomised studyMark Rosenthal, Warren Mason, Paul M. Clément et al.|ESMO Open|2020Cited by 35
A combined analysis of two prospective randomised studies exploring the impact of extended post-radiation temozolomide on survival outcomes in newly diagnosed glioblastomaLucy Gately, Carmen Balañá, Carlos Mesía et al.|Journal of Neuro-Oncology|2023Cited by 5
Correction to: A combined analysis of two prospective randomised studies exploring the impact of extended post-radiation temozolomide on survival outcomes in newly diagnosed glioblastomaLucy Gately, Carmen Balañá, Carlos Mesía et al.|Journal of Neuro-Oncology|2024Cited by 3
Blood-based prognostic scores and early dynamics under immunotherapy to select patients with metastatic solid tumors for continuing immune check-point inhibition: a prospective longitudinal studyJavier Garciá Corbacho, Francesco Schettini, Joan Maurel et al.|Cancer Immunology Immunotherapy|2025Cited by 3
Exploring management and outcomes of elderly patients with glioblastoma using data from two randomised trials (GEINO1401/EX-TEM)Lucy Gately, Carmen Balañá, Carlos Mesía et al.|Journal of Neuro-Oncology|2024Cited by 2